Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Short-term prophylaxis with cefotaxime for prostatic surgery.

T B Hargreave, J R Hindmarsh, R Elton

    British Medical Journal (Clinical Research Ed.)
    |April 3, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Blood transfusions increase the risk of venous thromboembolism following ventral hernia repair.

    Hernia : the journal of hernias and abdominal wall surgery·2019
    Same author

    Laparoscopic hernia complexity predicts operative time and length of stay.

    Hernia : the journal of hernias and abdominal wall surgery·2014
    Same author

    The effects of windrow composting on the viability of Parascaris equorum eggs.

    Veterinary parasitology·2012
    Same author

    The modification and standardisation of the Harter self-esteem questionnaire with Scottish school children.

    European child & adolescent psychiatry·2011
    Same author

    Distribution of gentamicin in body fluids.

    British medical journal·2010
    Same author

    The quality, safety and content of telephone and face-to-face consultations: a comparative study.

    Quality & safety in health care·2010

    Cefotaxime prophylaxis significantly reduced postoperative complications and hospital stays for men undergoing prostate surgery. This broad-spectrum antibiotic proved safe and effective in an elderly population, enhancing surgical outcomes.

    Area of Science:

    • Urology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Transurethral resection of the prostate (TURP) is associated with postoperative complications, including bacteriuria and febrile episodes.
    • Prophylactic antibiotics are often used to mitigate these risks, but optimal agents and durations are debated.

    Purpose of the Study:

    • To evaluate the efficacy and safety of 48-hour cefotaxime prophylaxis in reducing postoperative complications following TURP.
    • To assess the impact of cefotaxime on bacteriuria, febrile episodes, tachycardia, and hospital length of stay.

    Main Methods:

    • A randomized controlled trial was conducted involving men undergoing TURP.
    • Patients received either cefotaxime prophylaxis or no prophylaxis.
    • Outcomes measured included postoperative bacteriuria, febrile episodes, tachycardia, renal function (urea and creatinine), and hospital stay.

    Related Experiment Videos

    Main Results:

    • Cefotaxime prophylaxis significantly reduced postoperative bacteriuria, febrile episodes, and tachycardia compared to the control group.
    • Patients receiving cefotaxime experienced fewer overall complications and had an average one-day shorter hospital stay.
    • No significant differences in postoperative urea or creatinine levels were observed, indicating no nephrotoxicity.

    Conclusions:

    • Forty-eight-hour cefotaxime prophylaxis is effective in reducing postoperative complications and improving outcomes after TURP.
    • Cefotaxime is a safe and well-tolerated prophylactic agent in elderly patients undergoing prostatic surgery.
    • Cefotaxime prophylaxis can enhance the safety of prostatic surgery.